Actively Recruiting
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Led by Oslo University Hospital · Updated on 2025-03-30
40
Participants Needed
1
Research Sites
207 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This prospective clinical cohort study will follow 40 patients who recieve botulinum toxin A treatment for proximal medial gastrocnemius tightness with subsequent Chronic Plantar Fasciitis for two years. Three injections of botulinum toxin (75IU) will be administered with intervals of three months. Participants will be followed at baseline, 3 months, 6 months, 1 year and 2 years with Patient Related Outcome Measures (PROMS) and physical test (Ergotest and ankle dorsiflexion).
CONDITIONS
Official Title
Treatment of Gastrocnemius Tightness and Subsequent Chronic Plantar Fasciitis with Botulinum Toxin a
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18-75 years
- Confirmed gastrocnemius contracture by the Silfverski ds test
- Clinical diagnosis of plantar fasciitis by an orthopaedic surgeon
- MRI verification showing plantar fascia thickening, calcaneus edema, or pathological signals
- Symptoms lasting at least 12 months before first injection
- At least three months of physical therapy without significant symptom improvement
You will not qualify if you...
- Previous surgery for plantar fasciitis
- Severe talocrural problems or serious foot and ankle malalignment
- Severely reduced peripheral circulation
- History of alcoholism, drug abuse, or psychological/emotional issues affecting consent
- Inability to undergo or comply with MRI examination
- Allergy or contraindication to botulinum toxin
- Inability to read or speak Scandinavian languages or English adequately
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Oslo University Hospital, Orthopedic Department Ullevål
Oslo, Oslo, Norway
Actively Recruiting
Research Team
E
Elisabet Ellingsen Husebye, MD PhD
CONTACT
M
Martin Riiser, MD Phd candidate
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here